JP Morgan Chase’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
Other funds holding CRBU
KCM
JP Morgan Chase's CRBU Position: Q3 2026 in Review
JP Morgan Chase increased its Caribou Biosciences (CRBU) stake by 16% in Q3 2026, buying an estimated $11K and bringing the position to 49,986 shares worth $62K. The position accounts for ﹤0.01% of the portfolio, ranked #6475.
JP Morgan Chase first reported a position in CRBU in Q3 2021 and has held it in 20 quarters since. The position peaked at $6.34M in Q3 2022. 147 funds tracked by Wall St. Rank hold CRBU as of Q3 2026.
- JP Morgan Chase held 49,986 shares of Caribou Biosciences worth $62K as of Q3 2026.
- JP Morgan Chase bought 7,057 Caribou Biosciences shares in Q3 2026, an estimated $11K.
- Caribou Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #6475 holding.
- JP Morgan Chase first reported a position in Caribou Biosciences in Q3 2021 and has held it in 20 quarters since.
- JP Morgan Chase's Caribou Biosciences position peaked at $6.34M in Q3 2022.
- 147 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.